Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evogene Ltd. - Ordinary Shares
(NQ:
EVGN
)
1.110
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evogene Ltd. - Ordinary Shares
< Previous
1
2
3
4
Next >
Preview: Evogene's Earnings
↗
November 16, 2022
Via
Benzinga
Canonic Launches Its High THC Medical Cannabis Products In Israel
↗
September 21, 2022
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in...
Via
Benzinga
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
↗
September 06, 2022
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Via
Benzinga
Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
↗
August 31, 2022
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year.
Via
Benzinga
Earnings Scheduled For August 31, 2022
↗
August 31, 2022
Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.
Via
Benzinga
Recap: Evogene Q4 Earnings
↗
March 10, 2022
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Outlook For Evogene
↗
August 30, 2022
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that Evogene will...
Via
Benzinga
ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
August 17, 2022
From
ICL Group LTD
Via
Business Wire
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
↗
August 17, 2022
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.
Via
Benzinga
Earnings Scheduled For March 10, 2022
↗
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
↗
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?
↗
May 26, 2022
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the...
Via
Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
↗
July 21, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...
Via
Benzinga
Evogene's Earnings: A Preview
↗
May 25, 2022
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Evogene will report...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
April 21, 2022
Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
Earnings Scheduled For May 26, 2022
↗
May 26, 2022
Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.
Via
Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
↗
April 21, 2022
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...
Via
Benzinga
Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash
↗
March 10, 2022
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced its
Via
Benzinga
A Preview Of Evogene's Earnings
↗
March 09, 2022
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board
↗
February 16, 2022
Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subs...
Via
Benzinga
Computational Biology Company Evogene Confirms Earnings Results Release Date
↗
February 15, 2022
Computational biology company Evogene Ltd. (NASDAQ:EVGN)&n...
Via
Benzinga
Evogene's Canonic Ships First Batch Of Unique Cannabis Varieties To Europe
↗
January 31, 2022
Medical grade cannabis products developer Canonic Ltd. and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has shipped the first batch of its unique cannabis varieties to Portugal, following...
Via
Benzinga
Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms
↗
January 18, 2022
Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ:
Via
Benzinga
Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth
↗
December 01, 2021
Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel...
Via
Benzinga
Topics
Cannabis
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
↗
November 19, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.
Via
Benzinga
Topics
Cannabis
Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public Companies
↗
November 17, 2021
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), the paren...
Via
Benzinga
Earnings Scheduled For November 17, 2021
↗
November 17, 2021
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion....
Via
Benzinga
Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of Schedule
↗
October 19, 2021
Evogene Ltd.'s (NASDAQ:EVGN) (TASE: EVGN) whol...
Via
Benzinga
Topics
Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021
↗
October 08, 2021
Upgrades UBS upgraded the previous rating for Northern Trust Corp (NASDAQ:
Via
Benzinga
Canonic Announces Pre-Launch of Medical Cannabis Products in Israel
↗
August 31, 2021
Canonic Ltd, a company focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-...
Via
Benzinga
Topics
Cannabis
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.